The U.S. Federal Trade Commission recovered $25 million as a settlement in its cases alleging deceptive advertising against marketers of four diet pills.
The FTC filed separate cases against the marketers, alleging that claims about weight loss and weight control were not supported by scientific evidence. In settling the matters, marketers of Xenadrine EFX, CortiSlim, TrimSpa, and One-A-Day WeightSmart surrendered cash and other assets worth at least $25 million and agreed to limit their future advertised claims, the agency said in a news release.
"You won't find weight loss in a bottle of pills that claims it has the latest scientific breakthrough or miracle ingredient," said FTC Chairman Deborah Platt Majoras. "Paying for fad science is a good way to lose cash, not pounds."
Besides fines and penalties, the settlements also stipulated that the marketers are barred from making claims regarding the products' benefits unless the claims can be substantiated by scientific evidence.
The FTC said the National Advertising Division of the Council of Better Business Bureaus referred some of these cases.
Copyright 2007 by United Press International
Related stories:
'Electronic' cigarettes leave WHO fuming
The World Health Organisation on Friday angrily denounced "bogus, untested, and false" claims that it endorses so-called electronic cigarettes as a means to stop smoking.
Most Consumers Misinterpret Meaning of Trans-Fat Information on Nutrition Facts Panel, Study Shows
Without an interpretive footnote or further information on recommended daily value, many consumers do not know how to interpret the meaning of trans-fat content on the Nutrition Facts panel, according to a new study by marketing researchers at the University of Arkansas.
Marketing of unproven genetic tests a threat to public health
No mechanism currently exists to ensure that genetic tests are supported by adequate evidence before they go to market, or that marketing claims are truthful and not misleading, according to a policy analysis to be published April 4 in
Science. Misleading claims about genetic tests may lead health-care providers and patients to make inappropriate decisions about which tests to take and how to use genetic tests that have potential for profound medical consequences, the authors argue.
IRS Leans On Auction Sites to Spill Customer Information
Language in the President Bush's budget requires that online auction houses such as eBay share personal data with the IRS. Privacy groups cry foul, saying this will only increase data theft and phishing scams.
Generics controversy issue widens
A dispute between the U.S. Justice Department and Federal Trade Commission over generic drugs is reportedly widening with implications for the drug firms.
India a topper in average e-com deals
With less than 4 percent of the total population using the Internet, Net-savvy dwellers of the World Wide Web may still be a minority in India, but when it comes to online shopping, Indians are increasingly proving that they can beat the world when it comes to buying with keyboards and clicks.
Dutch pub owners rebel against smoking law
Dutch pub owners have launched a coordinated resistance against a smoking ban introduced in June, taking their ashtrays out of short-lived storage and pooling cash to pay the resultant fines.
AAAS satellite image analysis reveals South Ossetian damage
Satellite images captured before and after the 7-8 August clash between Georgia, South Ossetian separatists and Russia reveal that 424 civilian structures near Tskhinvali were damaged by 19 August – although they appeared intact in images taken on 10 August and earlier, the American Association for the Advancement of Science (AAAS) has reported.